AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Predictive Factors of Autonomy Loss in Real-life Cohort

RecruitingNAAges 18 Years - anyAllHospices Civils de Lyon
💬

In plain words

What the trial is, and whether it could suit you

The Alzheimer's disease or related disorders (ADRD) are among the most disabling diseases because of their main features such as cognitive impairment, loss of functional autonomy and behavioural disorders. In absence of current curative treatment, the identification of the predictive risk factors of progression of the disease, evaluated through its main symptoms, represents a major stake of public health. The Investigators aim at developing a regional database, which includes the patient medical records on a prospective basis, in collaboration with the medical and administrative staff and with the University hospital computer science departments. The main objective is to study the predictive factors associated with change in functional autonomy level, measured every 6 to 12 months in centres across Region Auvergne Rhone-Alpes in France. The real-life study population will consist in ab

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patients aged 18 years and older, undergoing a medical visit in a memory center or neuro-cognition service * Patients living at home or in housing * Patients with memory impairment, at all stage of the disease Exclusion Criteria: * Patients in institution * Patients under legal protection * Patients with a hearing or visual impairment, which prevents carrying out examinations
💊

What it tests

  • no intervention
📍

Where

5 sites
Hôpital Dugoujon
Caluire-et-Cuire, France
Centre Hospitalier Lyon Sud
Lyon, France
Service de neuro-cognition et neuro-ophtalmologie du Groupement Hospitalier Est
Lyon, France
CHU Saint-Etienne
Saint-Etienne, France
Centre Mémoire de Ressources et de Recherche de Lyon
Villeurbanne, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy